搜尋結果
Recursion Pharmaceuticals CEO explains how AI could make drug development faster and less ...
CNBC· 2 小時前Recursion Pharmaceuticals is a clinical stage biotech company that received a $50 ...
Macrogenics Stock Drops 77% After Study Deaths
The Wall Street Journal· 4 小時前MacroGenics shares plunged 77.4% on Friday, erasing $773.2 million in market value ...
US bill to restrict WuXi AppTec, Chinese biotechs revised to give more time to cut ties
Reuters· 5 小時前A new version of a congressional bill that would restrict U.S. business with certain ... ...
Medicare Advantage: Triple Threat Mounts for Insurers
The Wall Street Journal· 6 小時前Often, seniors can enroll in Medicare Advantage plans at no additional premium costs. On an ann ...
US Health Officials to Spend $100 Million on Bird Flu Surveillance
Bloomberg· 7 小時前US health officials are putting more than $100 million toward ramping up surveillance of bird ...
Barclays upgrades a little-known biotech stock that it says can more than double
CNBC· 10 小時前This drug discovery stock can benefit from expansion of its breast cancer treatment.
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters· 12 小時前Moderna's shares fell 3% to $119.02 in early trading. The Food and Drug Administration' ...
Moderna says FDA delayed RSV vaccine approval to end of May
CNBC· 14 小時前Moderna on Friday said the Food and Drug Administration has delayed ...
India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
Reuters· 14 小時前, opens new tab to market its blockbuster obesity treatment drugs in India, the company's ...
A Drug for Cows Could Curb Methane Emissions from Meat and Dairy
Bloomberg· 17 小時前A Boston-based startup is developing a vaccine it says can reduce methane emissions from ...